Published Studies Related to Zithromax Injection (Azithromycin Injection)
Well-designed clinical trials related to Zithromax Injection (Azithromycin Injection)
[Efficacy assessment of azithromycin 1.5% eye drops versus tobramycin 0.3% on clinical signs of purulent bacterial conjunctivitis] [2010.04]
Efficacy and safety of azithromycin 1.5% eye drops for purulent bacterial conjunctivitis in pediatric patients. [2010.03]
Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial. [2008.06]
The comparison of single-dose ceftriaxone, five-day azithromycin, and ten-day amoxicillin/clavulanate for the treatment of children with acute otitis media. [2007.10]
Correlation between In vitro susceptibility and treatment outcome with azithromycin in gonorrhoea: A prospective study. [2007.10]
Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease: a randomized controlled trial. [2007.07]
Efficacy of azithromycin versus systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis. [2007.07]
3-day treatment with azithromycin 1.5% eye drops versus 7-day treatment with tobramycin 0.3% for purulent bacterial conjunctivitis: multicentre, randomised and controlled trial in adults and children. [2007.04]
Clinical and bacteriological outcomes in hospitalised patients with community-acquired pneumonia treated with azithromycin plus ceftriaxone, or ceftriaxone plus clarithromycin or erythromycin: a prospective, randomised, multicentre study. [2007.02]
Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. [2005.09.22]
Effectiveness of syphilis treatment using azithromycin and/or benzathine penicillin in Rakai, Uganda. [2005.01]
Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults. [2003.08]
A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis. [2002.08]
Randomized, placebo-controlled clinical trial of oral azithromycin prophylaxis against respiratory infections in a high-risk, young adult population. [2001.10.01]
Comparison of azithromycin and ceftriaxone for the treatment of chancroid. [1995.08]
Efficacy and safety of azithromycin versus benzylpenicillin or erythromycin in community-acquired pneumonia. [1995.03]
Multicenter trial of single-dose azithromycin vs. ceftriaxone in the treatment of uncomplicated gonorrhea. Azithromycin Gonorrhea Study Group. [1994.03]
Well-designed clinical trials possibly related to Zithromax Injection (Azithromycin Injection)
Antimicrobial resistance and ophthalmic antibiotics: 1-year results of a longitudinal controlled study of patients undergoing intravitreal injections. [2011.09]
Ophthalmic antibiotics and antimicrobial resistance a randomized, controlled study of patients undergoing intravitreal injections. [2011.07]
Clinical efficacy of dexamethasone for acute exudative pharyngitis. [2008.11]
A comparative study of injection placentrex and conventional therapy in treatment of pelvic inflammatory disease. [2008.07]
Clinical efficacy of dexamethasone for acute exudative pharyngitis. [2008.05.10]
Comparative effects of single-dose ceftriaxone versus three oral antibiotic regimens on stool colonization by resistant bacilli in children. [2007.01]
The effects of intravenous doxycycline therapy for rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. [2001.05]
A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. [1998.07.09]
Other research related to Zithromax Injection (Azithromycin Injection)
The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus
azithromycin as treatment of uncomplicated gonorrhea. [2014]
Both combined oral azithromycin plus allopurinol and intramuscular Glucantime
yield low efficacy in the treatment of Old World cutaneous leishmaniasis: a
randomized controlled clinical trial. [2012]
Toxicity comparison of intraocular azithromycin with and without a bioadhesive delivery system in rabbit eyes. [2011.11.09]
[Combined pharmacological-surgical treatment in exudative age-related macular degeneration]. [2011]
High azithromycin loading powders for inhalation and their in vivo evaluation in rats. [2010.08.16]
[Continuous versus intermittent azithromycin administration for treatment of Mycoplasma pneumonia-induced pneumonia: effects and drug resistance in rats.] [2010.08]
Elevated tacrolimus levels associated with intravenous azithromycin and ceftriaxone: a case report. [2010.06]
Penetration of azithromycin in experimental pleural empyema fluid. [2010.01.25]
[Efficacy assessment of azithromycin 1.5% eye drops versus tobramycin 0.3% on
clinical signs of purulent bacterial conjunctivitis]. [Article in French] [2010]
Subinhibitory concentrations of telithromycin, clarithromycin and azithromycin reduce methicillin-resistant Staphylococcus aureus coagulase in vitro and in vivo. [2008.03]
The activity of azithromycin against Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis in the golden hamster model. [2007.11]
Tissue disposition of azithromycin after intravenous and intramuscular administration to rabbits. [2007.07]
Effect of timing and duration of azithromycin therapy of leptospirosis in a hamster model. [2007.01]
Pharmacokinetics and tissue tolerance of azithromycin after intramuscular administration to rabbits. [2006.12]
3-day treatment with Azithromycin 1.5% eye-drops (Azyter(R)) versus 7-day treatment with Tobramycin 0.3% for purulent bacterial conjunctivitis: multicentre, randomised and controlled trial in adults and children. [2006.10.18]
Concentrations of erythromycin and azithromycin in mature Chinook salmon Oncorhynchus tshawytscha after intraperitoneal injection, and in their progeny. [2006.03.02]
Pharmacokinetics of azithromycin in the blue and gold macaw (Ara ararauna) after intravenous and oral administration. [2005.12]
Pharmacokinetics of azithromycin after i.v. and i.m. administration to sheep. [2005.10]
Pharmacokinetics of azithromycin after intravenous and intramuscular administration to goats. [2005.02]
The cost-effectiveness of single-dose azithromycin for treatment of incubating syphilis. [2003.06]
Azithromycin metabolite identification in plasma, bile, and tissues of the ball python (Python regius). [2003.04]
[Clinic efficacy of treating chronic prostatitis caused by Neisseria gonorrhoeae with azithromycin aspartic-acid injection] [2003.02]
In vitro and ex vivo effects of erythromycin A, azithromycin and josamycin on the splenic response to specific antigens and mitogens. [2002.06]
Pharmacokinetics of azithromycin in foals after i.v. and oral dose and disposition into phagocytes. [2002.04]
Pharmacokinetics of azithromycin and concentration in body fluids and bronchoalveolar cells in foals. [2001.12]
Possible interaction between intravenous azithromycin and oral cyclosporine. [2001.11]
Chlamydial conjunctivitis in contact lens wearers: successful treatment with single dose azithromycin. [2001.10]
Azithromycin versus erythromycin for community-acquired pneumonia: a cost-minimization analysis. [1999.08.01]
Intravenous azithromycin-induced ototoxicity. [1999.02]
Activity of azithromycin as a blood schizonticide against rodent and human plasmodia in vivo. [1995.02]
Pharmacokinetics, oral bioavailability and tissue distribution of azithromycin in cats. [1995.02]
Other possibly related research studies
Effect of cirrhosis on antibiotic efficacy in a rat model of pneumococcal pneumonia. [2005.02]
Prophylaxis for opportunistic infections among HIV-infected patients receiving medical care. [1998.12.01]
[The particular case of azalides: antibiotic diapedesis. Experimental data from a murine model of pneumococcal pneumonia] [1995.06]
Effects of two antibiotic regimens on course and persistence of experimental Chlamydia pneumoniae TWAR pneumonitis. [1995.01]
Suppressive activity of macrolide antibiotics on nitric oxide production by lipopolysaccharide stimulation in mice. [2003.08]
Interventions for treating melioidosis. [2002]
Management issues in syphilis. [2002]
Treatment of community-acquired pneumonia in hospitalised patients. [2001]
Experiences at a large teaching hospital with levofloxacin for the treatment of community-acquired pneumonia. [2000.11.15]
Predicting injection site muscle damage. I: Evaluation of immediate release parenteral formulations in animal models. [1996.10]
Macrolide antibiotics in paediatric infectious diseases. [1996.04]
Group A streptococcal tonsillopharyngitis: cost-effective diagnosis and treatment. [1995.03]
[Stage-oriented treatment of Lyme borreliosis] [2006.06.22]
Evaluation of clinician-reported adherence to Centers for Disease Control and Prevention guidelines for the treatment of Chlamydia trachomatis in two U.S. health plans. [2006.04]
Pneumonia outbreak associated with group a Streptococcus species at a military training facility. [2005.02.15]
Experimental pleurodesis induced by antibiotics (macrolides or quinolones). [2006.12]
Cutaneous leishmaniasis treatment. [2007.05]
Emergency department drug orders: does drug storage location make a difference? [2007.10]
Evaluation of tulathromycin in the treatment of pulmonary abscesses in foals. [2007.09]
Amiodarone modulates pharmacokinetics of low-dose methotrexate in rats. [2008.07]
Probable enoxaparin-induced hepatotoxicity. [2009.04.01]
Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations. [2009]
Survival of Naegleria fowleri primary amebic meningocephalitis (PAM) could be improved with an intensive multi-route chemo- and biotherapeutic regimen. [2008.12]
[Mucocutaneous abnormalities in Chlamydia trachomatis-induced reactive arthritis] [2010]
A new strategy for the identification of novel molecules with targeted proresolution of inflammation properties. [2010.02.01]
Ophthalmic antibiotic use and multidrug-resistant staphylococcus epidermidis: a controlled, longitudinal study. [2011.10]
Maternal-amniotic-fetal distribution of macrolide antibiotics following intravenous, intramuscular, and intraamniotic administration in late pregnant sheep. [2011.06]
An anterior chamber toxicity study evaluating Besivance, AzaSite, and Ciprofloxacin. [2010.10]
Genital ulcer disease treatment for reducing sexual acquisition of HIV. [2012]
Antimicrobial resistance and ophthalmic antibiotics: 1-year results of a
longitudinal controlled study of patients undergoing intravitreal injections. [2011]
Ophthalmic antibiotic use and multidrug-resistant staphylococcus epidermidis: a
controlled, longitudinal study. [2011]
Ophthalmic antibiotics and antimicrobial resistance a randomized, controlled
study of patients undergoing intravitreal injections. [2011]
Changes in ocular flora in eyes exposed to ophthalmic antibiotics. [2013]
|